News

July 4, 2025

Unlock the full potential of your mRNA with ExploRNA’s Cap Analogs 5’ cap structure is a crucial element of every eukaryotic mRNA molecule. Beyond its well-known role in protecting mRNA against premature degradation and initiation of translation, it is...

June 4, 2025

On the 24th of June in NYC our CEO Jacek Jemielity will present at “mRNA Horizons: Investor Summit for Breakthroughs in Medicine”, an event organised by Alliance for mRNA Medicines and astr partners. Join Jacek, Tomasz Piec, Piotr Stępniak...

June 4, 2025

We are looking forward to the next week at Biotechnology Innovation Organization International Convention in Boston! If you haven’t already, plan to stop by The Poland Pavilion (# 672) or schedule a meeting with our Member of the Board...

April 22, 2025

We are proud to announce that ExploRNA Therapeutics has gained ISO 9001:2015 Certification from LL-C (Certification) for its quality management system, applicable to the production and sale of nucleotides, nucleic acids, and their derivatives. ISO 9001 is a globally...

March 3, 2025

We are moments away from the RNA Leaders Europe Congress in Basel. It is a perfect opportunity to talk to Tomasz Piec and Piotr Stępniak about our new cap analogs. Find out more and get inspired to create better...

February 28, 2025

Our CEO, prof. Jacek Jemielity was invited to give a seminar at the RNA Therapeutics Institute at UMass Chan Medical School. We are very proud for our leader to be recognised by the top RNA scientists in the world....

October 2, 2024

We are proud to announce that our Director of Business Development, Piotr Stępniak, will have the honor to speak at the Polish Embassy at a special event organised to promote Polish innovative biotechnology sector in front of esteemed guests...

September 3, 2024

San Diego, CA, USA and Warsaw, Poland – September 3, 2024 – Primrose Bio, a leading biotechnology company specializing in technologies that improve the manufacturing of next-generation therapeutics, and ExPLoRNA Therapeutics, a pioneering biotechnology company advancing mRNA technologies, vaccines,...

August 22, 2024

The Polish Healthcare Assets – Sector Event (PHASE) quickly became the Polish largest public discussion about medical biotechnology. It brings together industry leaders, venture capital, public institutions, and scientists, all debating the development of the sector. During this year’s...

March 8, 2024

We are happy to share that our most recent work has been featured in the Journal of American Chemical Society. This has been a great collaboration with University of Warsaw and we’d like to thank our partners and team...